VC Co-Working Day: Life Sciences Investment
Join us for the next installment of our monthly series designed to bring together NYC’s early-stage life sciences investor ecosystem - Pre-Seed to Series A investors backing breakthroughs across therapeutics, diagnostics, medical devices, synthetic biology, genomics, cell and gene therapy, immuno-oncology, tissue engineering, digital health, animal health, agricultural biotech, and beyond - for meaningful deal-sharing and curated co-working.
This session is proudly sponsored by Wilson Sonsini.
Schedule
9:00 - 10:30 AM: Deal Flow Breakfast
We’ll kick off the day with a curated breakfast for a select group of investors focused on life sciences to share and discuss live deals. Registration for the breakfast also provides full access to co-working until 5:00 PM, so there’s no need to sign up for both - registering for this session automatically includes the Co-Working Day.
10:30 AM - 5:00 PM: VC Co-Working
We are opening up our office to investors in our network and yours for informal working time and deeper one-on-one conversations. You’ll find plenty of desks in our open-office space to settle in, as well as private huddle rooms available throughout the day if you need to take calls or hold meetings.
About our Sponsor and Partner
Wilson Sonsini has a 60-plus year history of representing trailblazers in the life sciences industry - from the earliest innovators to those that are shaping the future of healthcare today. We work closely with entrepreneurs, scientists, and investors who trust Wilson Sonsini’s strategic advice to establish and realize their companies’ business objectives, which includes protecting and leveraging their most valuable IP assets. We represent life sciences companies through the entire business life cycle, from formation through IPO and strategic partnerships. We often act as outside general counsel with support from our cross-functional, global life sciences team to provide coordinated and comprehensive counsel to clients.
Our clients include thousands of innovation-focused life sciences companies, research institutions, start-up accelerators and incubators, and the venture capital funds and banks that finance the industry. A central pillar of our life sciences practice is our longstanding representation of medical device and biopharmaceutical companies, entrepreneurs, and investors, which dates back to these industries’ inception.
Wilson Sonsini’s life sciences practice is anchored by a diverse team of attorneys, patent agents, and scientific advisors, more than 100 of whom hold Ph.D.s and have significant industry experience. The team also includes former in-house legal counsel for major life sciences companies, an internationally recognized leader in the field of technology transfer, and former senior officials at U.S. federal agencies, such as the U.S. Patent and Trademark Office (USPTO) and the Patent Trial and Appeal Board (PTAB).